Found: 5
Select item for more details and to access through your institution.
Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 902, doi. 10.1177/10781552231196130
- By:
- Publication type:
- Article
Imatinib plasma levels in patients with gastrointestinal stromal tumour under routine clinical practice conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1613, doi. 10.1177/10781552221143788
- By:
- Publication type:
- Article
Imatinib plasma levels in patients with chronic myeloid leukaemia under routine clinical practice conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 40, doi. 10.1177/10781552211052535
- By:
- Publication type:
- Article
Patient-reported outcomes and digital literacy of patients treated in an oncology day hospital unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 530, doi. 10.1177/1078155221996041
- By:
- Publication type:
- Article
Vancomicina frente a daptomicina como tratamiento de las bacteriemias asociadas a catéter y causadas por grampositivos en el paciente oncológico .
- Published in:
- Farmacia Hospitalaria (1130-6343), 2022, v. 46, n. 3, p. 105, doi. 10.7399/fh.11724
- By:
- Publication type:
- Article